Use of the rheumatic drug tocilizumab for treatment of SARS-CoV-2 patients
Coronavirus disease 2019 (COVID-19) is a highly infectious respiratory disease caused by a new coronavirus known as severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which has been observed to vary in its degree of symptoms. One of the most important clinical manifestations is pneumonia...
Enregistré dans:
| Auteurs principaux: | , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Termedia Publishing House
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/76f5289ab74b4934bde3bedbbad502ab |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|